Is Ryaltris a Controlled Substance? No

No. Ryaltris (olopatadine and mometasone furoate) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and olopatadine and mometasone furoate is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Ryaltris?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Ryaltris
Source	What it lists
FDA NDC directory	2 prescription listings from 2 labelers, none with a DEA schedule
DEA controlled substances list	olopatadine and mometasone furoate is not on the list

Ryaltris NDC listings

NDC listings for Ryaltris
NDC	Product	Form	Strength	Labeler	DEA schedule
59467-700	Ryaltris	spray, metered	665 ug/1; 25 ug/1	HIKMA SPECIALTY USA INC.	None
68462-659	Ryaltris	spray, metered	665 ug/1; 25 ug/1	Glenmark Pharmaceuticals Inc., USA	None

Questions

Is Ryaltris a controlled substance?

No. Ryaltris (olopatadine and mometasone furoate) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and olopatadine and mometasone furoate is not on the DEA controlled substances list.

Is Ryaltris a narcotic?

No. Ryaltris (olopatadine and mometasone furoate) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Corticosteroid and Histamine-1 Receptor Antagonist and Histamine-1 Receptor Inhibitor and Mast Cell Stabilizer.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.